Alisertib treatment of relapsed or refractory peripheral T-cell lymphoma: disappointing results

被引：0
|
作者：
Paillassa, Jerome
机构：
来源：
HEMATOLOGIE | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：130 / 131
页数：2
相关论文
共 50 条
  • [21] Mogamulizumab Monotherapy in the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma or Cutaneous T-Cell Lymphoma Patients in Single-Institution Experience
    Murai, Kazunori
    Hiroyuki, Hamada
    Sato, Akiyoshi
    Yasuro, Miyairi
    Mori, Yasuki
    Sakuma, Tsutomu
    BLOOD, 2017, 130
  • [22] Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study
    Kim, Won-Seog
    Fukuhara, Noriko
    Yoon, Dok-Hyun
    Yamamoto, Kazuhito
    Uchida, Toshiki
    Negoro, Eiju
    Izutsu, Koji
    Terui, Yasuhito
    Nakajima, Hideaki
    Ando, Kiyoshi
    Suehiro, Youko
    Kang, Hye Jin
    Ko, Po-Shen
    Nagahama, Fumiko
    Sonehara, Yusuke
    Nagai, Hirokazu
    Tien, Hwei-Fang
    Kwong, Yok-Lam
    Tobinai, Kensei
    BLOOD ADVANCES, 2023, 7 (17) : 4903 - 4912
  • [23] Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study
    O'Connor, Owen A.
    Pro, Barbara
    Pinter-Brown, Lauren
    Bartlett, Nancy
    Popplewell, Leslie
    Coiffier, Bertrand
    Lechowicz, Mary Jo
    Savage, Kerry J.
    Shustov, Andrei R.
    Gisselbrecht, Christian
    Jacobsen, Eric
    Zinzani, Pier Luigi
    Furman, Richard
    Goy, Andre
    Haioun, Corinne
    Crump, Michael
    Zain, Jasmine M.
    Hsi, Eric
    Boyd, Adam
    Horwitz, Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (09) : 1182 - 1189
  • [24] The role of alisertib in treatment of peripheral T-cell lymphomas
    Gallop-Evans, Eve
    FUTURE ONCOLOGY, 2015, 11 (18) : 2515 - 2524
  • [25] Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified
    Zinzani, Pier Luigi
    Pellegrini, Cinzia
    Broccoli, Alessandro
    Stefoni, Vittorio
    Gandolfi, Letizia
    Quirini, Federica
    Argnani, Lisa
    Berti, Emilio
    Derenzini, Enrico
    Pileri, Stefano
    Baccarani, Michele
    LEUKEMIA & LYMPHOMA, 2011, 52 (08) : 1585 - 1588
  • [26] Belinostat in patients with refractory or relapsed peripheral T-cell lymphoma: a perspective review
    Sawas, Ahmed
    Radeski, Dejan
    O'Connor, Owen A.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2015, 6 (04) : 202 - 208
  • [27] Pilot study of sorafenib in relapsed or refractory peripheral and cutaneous T-cell lymphoma
    Gibson, Juliet Fraser
    Foss, Francine
    Cooper, Dennis
    Seropian, Stuart
    Irizarry, Diana
    Barbarotta, Lisa
    Lansigan, Frederick
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (01) : 141 - 144
  • [28] Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma
    Mridula Krishnan
    R. Gregory Bociek
    Michelle Fanale
    Swaminathan P. Iyer
    Mary Jo Lechowicz
    Philip J. Bierman
    James O. Armitage
    Matthew Lunning
    Avyakta Kallam
    Julie M. Vose
    Annals of Hematology, 2022, 101 : 335 - 340
  • [29] Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma
    Krishnan, Mridula
    Bociek, R. Gregory
    Fanale, Michelle
    Iyer, Swaminathan P.
    Lechowicz, Mary Jo
    Bierman, Philip J.
    Armitage, James O.
    Lunning, Matthew
    Kallam, Avyakta
    Vose, Julie M.
    ANNALS OF HEMATOLOGY, 2022, 101 (02) : 335 - 340
  • [30] Safety and Efficacy of Pralatrexate in the Management of Relapsed or Refractory Peripheral T-cell Lymphoma
    Rodd, Annabelle L.
    Ververis, Katherine
    Karagiannis, Tom C.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6 : 305 - 314
12345